TSX:CURAPharmaceuticals
Assessing Curaleaf Holdings (TSX:CURA) Valuation After Strong Revenue And Ongoing Net Loss
Why Curaleaf Holdings (TSX:CURA) Is Back on Investor Radars
Curaleaf Holdings (TSX:CURA) has caught investor attention after delivering full year revenue of $1,268.135 million alongside a net loss of $247.114 million, raising fresh questions about how to interpret its recent share performance.
See our latest analysis for Curaleaf Holdings.
At a share price of CA$2.98, Curaleaf’s 1 month share price return of 11.83% and 3 month share price return of 20.74% show pressure building on the recent...